FDA Inspection 1217513 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on Sep 7, 2023 in Rye, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 7, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Rye, NY (United States)